171 related articles for article (PubMed ID: 32994701)
61. Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer.
Banegas MP; Hassett MJ; Keast EM; Carroll NM; O'Keeffe-Rosetti M; Fishman PA; Uno H; Hornbrook MC; Ritzwoller DP
Value Health; 2022 Jan; 25(1):69-76. PubMed ID: 35031101
[TBL] [Abstract][Full Text] [Related]
62. Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.
de Maar JS; Luyendijk M; Suelmann BBM; van der Kruijssen DEW; Elias SG; Siesling S; van der Wall E
Breast Cancer Res Treat; 2023 Apr; 198(2):253-264. PubMed ID: 36648694
[TBL] [Abstract][Full Text] [Related]
63. Radiation therapy of the primary tumour and oligometastatic sites in patients with breast cancer with synchronous metastases: A literature review.
Le Scodan R; Ghannam Y; Kirova Y; Bourgier C; Richard Tallet A
Cancer Radiother; 2024 Feb; 28(1):3-14. PubMed ID: 38065784
[TBL] [Abstract][Full Text] [Related]
64. Presentation and outcomes of KRAS
Esfahanian N; Chan SWS; Zhan LJ; Brown MC; Khan K; Lee J; Balaratnam K; Yan E; Parker J; Garcia-Pardo M; Barghout SH; Eng L; Bradbury PA; Shepherd FA; Leighl NB; Sacher AG; Snow S; Juergens R; Liu G
Cancer Treat Res Commun; 2023; 37():100774. PubMed ID: 37979334
[TBL] [Abstract][Full Text] [Related]
65. Primary site surgery of de novo stage IV HER2-positive breast cancer in the era of new drug treatments.
Lu G; Jia L; Yang R; Liu Y; Lv Z; Cui J
Front Oncol; 2023; 13():1308854. PubMed ID: 38264738
[TBL] [Abstract][Full Text] [Related]
66. Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?
Criscitiello C; Giuliano M; Curigliano G; De Laurentiis M; Arpino G; Carlomagno N; De Placido S; Golshan M; Santangelo M
Eur J Surg Oncol; 2015 Oct; 41(10):1288-92. PubMed ID: 26238477
[TBL] [Abstract][Full Text] [Related]
67. Can Women With HER2-Positive Metastatic Breast Cancer Be Cured?
Haji F; Hurvitz SA
Clin Breast Cancer; 2021 Dec; 21(6):526-531. PubMed ID: 34334312
[TBL] [Abstract][Full Text] [Related]
68. Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa.
Pumpalova YS; Ayeni OA; Chen WC; O'Neil DS; Nietz S; Phakathi B; Buccimazza I; Čačala S; Stopforth LW; Farrow HA; Joffe M; Mapanga W; Jacobson JS; Crew KD; Cubasch H; Ruff P; Neugut AI
Breast Cancer Res Treat; 2021 Aug; 189(1):285-296. PubMed ID: 34125339
[TBL] [Abstract][Full Text] [Related]
69. Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy.
Tinterri C; Sagona A; Barbieri E; Di Maria Grimaldi S; Jacobs F; Zambelli A; Trimboli RM; Bernardi D; Vinci V; Gentile D
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551722
[TBL] [Abstract][Full Text] [Related]
70. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
[TBL] [Abstract][Full Text] [Related]
71. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.
Hassett MJ; Banegas M; Uno H; Weng S; Cronin AM; O'Keeffe Rosetti M; Carroll NM; Hornbrook MC; Ritzwoller DP
J Oncol Pract; 2019 Jul; 15(7):e616-e627. PubMed ID: 31107629
[TBL] [Abstract][Full Text] [Related]
72. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.
Takiar V; Akay CL; Stauder MC; Tereffe W; Alvarez RH; Hoffman KE; Perkins GH; Strom EA; Buchholz TA; Ueno NT; Babiera G; Woodward WA
Springerplus; 2014; 3():166. PubMed ID: 24711988
[TBL] [Abstract][Full Text] [Related]
73. Exploring the Value of Additional Primary Tumour Excision Combined with Systemic Therapy Administered in Different Sequences for Patients with de Novo Metastatic Breast Cancer.
Zhu S
Breast J; 2022; 2022():5049445. PubMed ID: 36082023
[TBL] [Abstract][Full Text] [Related]
74. Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.
Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka S; Bebb DG; Cheung WY
Am J Clin Oncol; 2019 Jan; 42(1):75-81. PubMed ID: 30211724
[TBL] [Abstract][Full Text] [Related]
75. Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?
Heller DR; Chiu AS; Farrell K; Killelea BK; Lannin DR
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30965658
[No Abstract] [Full Text] [Related]
76. HR
Torrisi R; Jacobs F; Miggiano C; De Sanctis R; Santoro A
Drugs Context; 2023; 12():. PubMed ID: 36926051
[TBL] [Abstract][Full Text] [Related]
77. Prognostic factors and the role of locoregional treatment in patients with distantly metastatic hypopharyngeal cancer: a retrospective cohort study based on SEER database.
Wang W; Zheng H; Yu L; Zhang L
Ann Palliat Med; 2022 Jun; 11(6):1925-1939. PubMed ID: 35073716
[TBL] [Abstract][Full Text] [Related]
78. [Locoregional surgery for stage IV breast cancer patients].
Lotersztajn N; Héquet D; Mosbah R; Rouzier R
Gynecol Obstet Fertil; 2015 Apr; 43(4):304-8. PubMed ID: 25819388
[TBL] [Abstract][Full Text] [Related]
79. Clinicopathologic factors associated with de novo metastatic breast cancer.
Shen T; Siegal GP; Wei S
Pathol Res Pract; 2016 Dec; 212(12):1167-1173. PubMed ID: 27692496
[TBL] [Abstract][Full Text] [Related]
80. Palliative care utilization and racial and ethnic disparities among women with de novo metastatic breast cancer in the United States.
Giap F; Ma SJ; Oladeru OT; Hong YR; Yu B; Mailhot Vega RB; Brooks ED; Singh AK; Okunieff PG; Mendenhall NP; Bradley JA
Breast Cancer Res Treat; 2023 Aug; 200(3):347-354. PubMed ID: 37269438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
